Besremi Alternatives Compared
Besremi (ropeginterferon alfa-2b) | Hydroxyurea | Jakafi (ruxolitinib) |
|
---|
Besremi (ropeginterferon alfa-2b) | Hydroxyurea | Jakafi (ruxolitinib) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Polycythemia Vera. Besremi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Myelogenous Leukemia, Sickle Cell Anemia, Glioblastoma Multiforme, Cervical Cancer, Head and Neck Cancer, Plaque Psoriasis, Polycythemia Vera, Psoriasis, Psoriatic Arthritis... View more |
Prescription only
Prescribed for Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Myeloproliferative Disorders. Jakafi may also be used for purposes not listed in this medication guide. |
Related suggestions Polycythemia Vera
|
|||||||||||||||||||||||
More about Besremi (ropeginterferon alfa-2b) | More about Hydroxyurea | More about Jakafi (ruxolitinib) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Hydroxyurea has an average rating of 7.0 out of 10 from a total of 47 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
Jakafi has an average rating of 7.5 out of 10 from a total of 33 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Besremi side effects |
View all Hydroxyurea side effects |
View all Jakafi side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Besremi prices |
View all Hydroxyurea prices |
View all Jakafi prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Droxia, Hydrea, Siklos, Xromi |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
240 hours |
4 hours |
5.8 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 450 drugs are known to interact with Besremi:
|
A total of 286 drugs are known to interact with Hydroxyurea:
|
A total of 510 drugs are known to interact with Jakafi:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
December 07, 1967 |
November 16, 2011 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Intron A
Intron A is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated lymphoid ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
PegIntron
PegIntron is used to treat chronic hepatitis C in adults. Learn about side effects, interactions ...
Sylatron
Sylatron (peginterferon alfa-2b) used to prevent malignant melanoma from coming back after it has ...
Ropeginterferon alfa-2b
Ropeginterferon alfa-2b systemic is used for polycythemia vera
Peginterferon alfa-2b
Peginterferon alfa-2b systemic is used for chronic myelogenous leukemia, hepatitis b, hepatitis c ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.